Thiogenesis Therapeutics
$0.44
1
+$0.05+13.9% Tuesday 17:45
Statistics
Day High
0.44
Day Low
0.44
52W High
2.58
52W Low
0
Volume
12,500
Avg. Volume
725
Mkt Cap
22.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-4.46MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TTIPF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.
Show more...
CEO
Country
Canada
ISIN
CA88410L1022
Listings
0 Comments
Share your thoughts
FAQ
What is Thiogenesis Therapeutics stock price today?▼
The current price of TTIPF is $0.44 USD — it has increased by +13.9% in the past 24 hours. Watch Thiogenesis Therapeutics stock price performance more closely on the chart.
What is Thiogenesis Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Thiogenesis Therapeutics stocks are traded under the ticker TTIPF.
What is Thiogenesis Therapeutics market cap?▼
Today Thiogenesis Therapeutics has the market capitalization of 22.81M
When is the next Thiogenesis Therapeutics earnings date?▼
Thiogenesis Therapeutics is going to release the next earnings report on May 13, 2026.
What were Thiogenesis Therapeutics earnings last quarter?▼
TTIPF earnings for the last quarter are -0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Thiogenesis Therapeutics revenue for the last year?▼
Thiogenesis Therapeutics revenue for the last year amounts to 0 USD.
What is Thiogenesis Therapeutics net income for the last year?▼
TTIPF net income for the last year is -4.46M USD.
In which sector is Thiogenesis Therapeutics located?▼
Thiogenesis Therapeutics operates in the Other sector.
When did Thiogenesis Therapeutics complete a stock split?▼
Thiogenesis Therapeutics has not had any recent stock splits.